12:00 AM
 | 
Jun 11, 2012
 |  BC Week In Review  |  Financial News  |  Other Financial News

PDL BioPharma financial update

PDL BioPharma amended the conversion rates for its outstanding convertible senior notes in connection with its regular dividend to be paid...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >